Human Antithrombin Market Size, Share & Industry Analysis, By Application (Therapeutic and Research & Diagnostic), By Dosage Form (Lyophilized Powder and Liquid), By End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Industry, and Research Institutes), and Regional Forecast, 2026-2034

Last Updated: January 19, 2026 | Format: PDF | Report ID: FBI113611

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Market Scope
2. Market Segmentation
3. Market Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Key Cardiovascolar Diseases, By Key Countries
2. Regolatory Scenario, By Key Countries
3. Key Industry Developments (Mergers, Acquisitions, Partnerships, Approvals, Launches etc.)
Global Human Antithrombin Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Application
  1. Therapeutic
  2. Research & Diagnostic
2. Market Analysis, Insights and Forecast – By Dosage Form
  1. Lyophilized Powder
  2. Liquid
3. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Pharmaceutical & Biotechnology Industry
  3. Research Institutes
4. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Rest of the World
North America Human Antithrombin Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Application
  1. Therapeutic
  2. Research & Diagnostic
2. Market Analysis, Insights and Forecast – By Dosage Form
  1. Lyophilized Powder
  2. Liquid
3. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Pharmaceutical & Biotechnology Industry
  3. Research Institutes
4. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Human Antithrombin Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Application
  1. Therapeutic
  2. Research & Diagnostic
2. Market Analysis, Insights and Forecast – By Dosage Form
  1. Lyophilized Powder
  2. Liquid
3. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Pharmaceutical & Biotechnology Industry
  3. Research Institutes
4. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Germany
  2. UK
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Human Antithrombin Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Application
  1. Therapeutic
  2. Research & Diagnostic
2. Market Analysis, Insights and Forecast – By Dosage Form
  1. Lyophilized Powder
  2. Liquid
3. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Pharmaceutical & Biotechnology Industry
  3. Research Institutes
4. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Japan
  2. China
  3. India
  4. Australia
  5. South Korea
  6. Southeast Asia
  7. Rest of Asia Pacific
Rest of World Human Antithrombin Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Application
  1. Therapeutic
  2. Research & Diagnostic
2. Market Analysis, Insights and Forecast – By Dosage Form
  1. Lyophilized Powder
  2. Liquid
3. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Pharmaceutical & Biotechnology Industry
  3. Research Institutes
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles
  1. CSL
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  2. Octapharma AG
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  3. Takeda Pharmaceutical Company Limited
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  4. Grifols, S.A.
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  5. Medix Biochemica
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  6. Kedrion S.p.A.
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  7. Scripps Laboratories
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.

Introduction
1. Market Scope
2. Market Segmentation
3. Market Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Key Cardiovascolar Diseases, By Key Countries
2. Regolatory Scenario, By Key Countries
3. Key Industry Developments (Mergers, Acquisitions, Partnerships, Approvals, Launches etc.)
Global Human Antithrombin Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Application
  1. Therapeutic
  2. Research & Diagnostic
2. Market Analysis, Insights and Forecast – By Dosage Form
  1. Lyophilized Powder
  2. Liquid
3. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Pharmaceutical & Biotechnology Industry
  3. Research Institutes
4. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Rest of the World
North America Human Antithrombin Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Application
  1. Therapeutic
  2. Research & Diagnostic
2. Market Analysis, Insights and Forecast – By Dosage Form
  1. Lyophilized Powder
  2. Liquid
3. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Pharmaceutical & Biotechnology Industry
  3. Research Institutes
4. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Human Antithrombin Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Application
  1. Therapeutic
  2. Research & Diagnostic
2. Market Analysis, Insights and Forecast – By Dosage Form
  1. Lyophilized Powder
  2. Liquid
3. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Pharmaceutical & Biotechnology Industry
  3. Research Institutes
4. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Germany
  2. UK
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Human Antithrombin Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Application
  1. Therapeutic
  2. Research & Diagnostic
2. Market Analysis, Insights and Forecast – By Dosage Form
  1. Lyophilized Powder
  2. Liquid
3. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Pharmaceutical & Biotechnology Industry
  3. Research Institutes
4. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Japan
  2. China
  3. India
  4. Australia
  5. South Korea
  6. Southeast Asia
  7. Rest of Asia Pacific
Rest of World Human Antithrombin Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Application
  1. Therapeutic
  2. Research & Diagnostic
2. Market Analysis, Insights and Forecast – By Dosage Form
  1. Lyophilized Powder
  2. Liquid
3. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Pharmaceutical & Biotechnology Industry
  3. Research Institutes
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles
  1. CSL
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  2. Octapharma AG
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  3. Takeda Pharmaceutical Company Limited
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  4. Grifols, S.A.
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  5. Medix Biochemica
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  6. Kedrion S.p.A.
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  7. Scripps Laboratories
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.

Read Less

List of Figures

Figure 1: Global Human Antithrombin Market Revenue Breakdown (USD million, %) by Region, 2025 & 2034

Figure 2: Global Human Antithrombin Market Value Share (%), by Application, 2025 & 2034

Figure 3: Global Human Antithrombin Market Value Share (%), by Dosage Form, 2025 & 2034

Figure 4: Global Human Antithrombin Market Value Share (%), by End User, 2025 & 2034

Figure 5: Global Human Antithrombin Market Value (USD million), by Region, 2025 & 2034

Figure 6: North America Human Antithrombin Market Value (USD million), by Application, 2025 & 2034

Figure 7: North America Human Antithrombin Market Value Share (%), by Application, 2025

Figure 8: North America Human Antithrombin Market Value (USD million), by Dosage Form, 2025 & 2034

Figure 9: North America Human Antithrombin Market Value Share (%), by Dosage Form, 2025

Figure 10: North America Human Antithrombin Market Value (USD million), by End User, 2025 & 2034

Figure 11: North America Human Antithrombin Market Value Share (%), by End User, 2025

Figure 12: North America Human Antithrombin Market Value (USD million), By Country, 2025 & 2034

Figure 13: North America Human Antithrombin Market Value Share (%), By Country, 2025

Figure 14: Europe Human Antithrombin Market Value (USD million), by Application, 2025 & 2034

Figure 15: Europe Human Antithrombin Market Value Share (%), by Application, 2025

Figure 16: Europe Human Antithrombin Market Value (USD million), by Dosage Form, 2025 & 2034

Figure 17: Europe Human Antithrombin Market Value Share (%), by Dosage Form, 2025

Figure 18: Europe Human Antithrombin Market Value (USD million), by End User, 2025 & 2034

Figure 20: Europe Human Antithrombin Market Value Share (%), by End User, 2025

Figure 21: Europe Human Antithrombin Market Value (USD million), By Country/ Sub-region, 2025 & 2034

Figure 22: Europe Human Antithrombin Market Value Share (%), By Country/ Sub-region, 2025

Figure 23: Asia Pacific Human Antithrombin Market Value (USD million), by Application, 2025 & 2034

Figure 24: Asia Pacific Human Antithrombin Market Value Share (%), by Application, 2025

Figure 25: Asia Pacific Human Antithrombin Market Value (USD million), by Dosage Form, 2025 & 2034

Figure 26: Asia Pacific Human Antithrombin Market Value Share (%), by Dosage Form, 2025

Figure 27: Asia Pacific Human Antithrombin Market Value (USD million), by End User, 2025 & 2034

Figure 28: Asia Pacific Human Antithrombin Market Value Share (%), by End User, 2025

Figure 29: Asia Pacific Human Antithrombin Market Value (USD million), By Country/ Sub-region, 2025 & 2034

Figure 30: Asia Pacific Human Antithrombin Market Value Share (%), By Country/ Sub-region, 2025

Figure 31: Rest of the World Human Antithrombin Market Value (USD million), by Application, 2025 & 2034

Figure 32: Rest of the World Human Antithrombin Market Value Share (%), by Application, 2025

Figure 33: Rest of the World Human Antithrombin Market Value (USD million), by Dosage Form, 2025 & 2034

Figure 34: Rest of the World Human Antithrombin Market Value Share (%), by Dosage Form, 2025

Figure 35: Rest of the World Human Antithrombin Market Value (USD million), by End User, 2025 & 2034

Figure 36: Rest of the World Human Antithrombin Market Value Share (%), by End User, 2025

Figure 37: Global Human Antithrombin Market Share (%), By Company, 2025

List of Tables

Table 1: Global Human Antithrombin Market Revenue (USD million) Forecast, by Application, 2021–2034

Table 2: Global Human Antithrombin Market Revenue (USD million) Forecast, by Dosage Form, 2021–2034

Table 3: Global Human Antithrombin Market Revenue (USD million) Forecast, by End User, 2021–2034

Table 4: Global Human Antithrombin Market Revenue (USD million) Forecast, by Region, 2021-2034

Table 5: North America Human Antithrombin Market Revenue (USD million) Forecast, by Application, 2021-2034

Table 6: North America Human Antithrombin Market Revenue (USD million) Forecast, by Dosage Form, 2021-2034

Table 7: North America Human Antithrombin Market Revenue (USD million) Forecast, by End User, 2021-2034

Table 8: North America Human Antithrombin Market Revenue (USD million) Forecast, By Country, 2021-2034

Table 9: Europe Human Antithrombin Market Revenue (USD million) Forecast, by Application, 2021-2034

Table 10: Europe Human Antithrombin Market Revenue (USD million) Forecast, by Dosage Form, 2021-2034

Table 11: Europe Human Antithrombin Market Revenue (USD million) Forecast, by End User, 2021-2034

Table 12: Europe Human Antithrombin Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034

Table 13: Asia Pacific Human Antithrombin Market Revenue (USD million) Forecast, by Application, 2021-2034

Table 14: Asia Pacific Human Antithrombin Market Revenue (USD million) Forecast, by Dosage Form, 2021-2034

Table 15: Asia Pacific Human Antithrombin Market Revenue (USD million) Forecast, by End User, 2021-2034

Table 16: Asia Pacific Human Antithrombin Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034

Table 17: Rest of the World Human Antithrombin Market Revenue (USD million) Forecast, by Application, 2021-2034

Table 18: Rest of the World Human Antithrombin Market Revenue (USD million) Forecast, by Dosage Form, 2021-2034

Table 19: Rest of the World Human Antithrombin Market Revenue (USD million) Forecast, by End User, 2021-2034

STUDY PERIOD: 2021-2034
BASE YEAR: 2025
HISTORICAL DATA: 2021-2024
NO OF PAGES: 100

Buy Now

Download Free Sample

Security Code

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
sales@fortunebusinessinsights.com